Drug Formulary, Quality Reporting, Prescription Database, Pharmaceutical Companies Sold, and Drug Rebates
In this week’s BioBlog we look at a new drug formulary, the new MACRA fact sheets, and the development of a universal prescription database. Also in the news the sale of pharmaceutical companies, and drug rebates that health plan providers receive.
This week The National Cancer Institute launched a new drug formulary that will give faster access to agents in clinical trials.
ASCO has developed a tool kit to help guide providers through the MACRA implementation process.
Novartis, Pfizer Join With Big Biopharma Peers to Create Tech Standards That Streamline How HCPs Access Info
More pharmaceutical companies are joining in the initiative to create one database for all drug information.
FiercePharmaAsia: Takeda’s $5.2B Deal for Ariad and $125M with Maverick, Valeant’s $820M Dendreon Sell to Chinese Company, and More
There has been a lot of movement recently in the sale of several drug companies.
This article discusses the recent uproar due to consumers being unhappy that their health plans receive a rebate on prescriptions, while they still pay full price.